---
f_featured: true
f_date: '2021-12-17T00:00:00.000Z'
f_source-url: >-
  https://msmagazine.com/2021/12/17/fda-abortion-pill-medication-biden-mifepristone/
f_include-in-latest-developments-on-providers-page: false
title: >-
  FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores
  the Science and Smacks of Political Interference”
f_publication: Ms. Magazine
f_author-2: Carrie N. Baker
slug: >-
  fda-lifts-some-abortion-pill-restrictions-leaves-others-in-place-ignores-the-science-and-smacks-of-political-interference
f_thumb:
  url: >-
    https://uploads-ssl.webflow.com/5f7e07d162248b2c1139d2ef/61c28932a70fce78168b64f7_Medication-Abortion-Care-Is-Safe-and-Effective%E2%80%94Its-Time-Everyone-Has-Equal-Access-1.jpg
  alt: null
f_posted-by: cms/author/plan-c.md
f_tags:
  - cms/media-tags/featured.md
  - cms/media-tags/legal.md
  - cms/media-tags/telemedicine.md
f_category:
  - cms/media-categories/press.md
updated-on: '2021-12-22T02:11:59.749Z'
created-on: '2021-12-22T02:11:59.749Z'
published-on: '2021-12-22T02:12:09.035Z'
layout: '[press].html'
tags: press
---

##### **_“_**_At a time when abortion care is under attack like never before, especially for folks working to make ends meet, we can’t afford partial solutions.”_

##### _—_**_Destiny Lopez, co-president of All\* Above All_**

On Thursday, the U.S. Food and Drug Administration (FDA) [lifted](https://www.aclu.org/letter/fda-rems-review-announcement-letter) a long-standing rule that health care providers must distribute the abortion pill mifepristone to patients in person, but left in place several burdensome restrictions that continue to unnecessarily restrict and stigmatize this safe medication, say advocates. The decision came in response to a [case](https://www.aclu.org/cases/chelius-v-becerra) filed by the ACLU on behalf of abortion providers and medical groups.

[Read the full article here.](https://msmagazine.com/2021/12/17/fda-abortion-pill-medication-biden-mifepristone/)

‍
